CLASS I Drug recall · Reported 28 Oct 2020 · FDA Enforcement Report

NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg) recalled

Acella Pharmaceuticals is recalling NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg), distributed nationwide in the US. The recall was initiated on 17 Sep 2020 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: M327E19-1 Exp. 10/2020
NDC42192-327, 42192-376, 42192-329, 42192-330, 42192-331, 42192-328
UPC0342192330016, 0342192329010, 0342192328013, 0342192331013
Quantity recalled19,296 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0035-2021
FDA event ID
86467
Recalling firm
Acella Pharmaceuticals, Alpharetta, GA
Manufacturer
Acella Pharmaceuticals, LLC
Classification
Class I
Status
Terminated
Recall initiated
17 Sep 2020
FDA classified
19 Oct 2020
Reported
28 Oct 2020
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Potency & Assay

Timeline

17 Sep 2020Recall initiated by company
19 Oct 2020Classified by FDA+32 days
28 Oct 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg) 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-327-01

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Which lots are affected?

Lot #: M327E19-1 Exp. 10/2020

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 86467
ReportedClassRecallCompanyReasonWhere
CLASS INP Thyroid 120, Thyroid Tablets, USP 2 grain (120 mg) recalledNp Thyroid 15Acella PharmaceuticalsPotency & AssayNationwide

More recalls from Acella Pharmaceuticals

All 16

Other Levothyroxine recalls

All 147